CALL US (888) 818-2059

For payors and risk-bearing health systems

Isaac Health partners with Medicare Advantage plans and risk-bearing health systems to offer population screening, diagnosis, and dementia care management services

Image of elderly lady undergoing cognitive testing

Dementia Is Common

1 in 3 Americans develop dementia

Dementia patients will triple by 2050

Access to diagnosis & treatment is restricted

  • 90% of physicians not comfortable with diagnosis/treatment
  • 61% of dementia is undiagnosed (potentially translating to significant losses in risk adjustment)

Waiting times are 6 – 12 months for memory clinics (set to increase to 50 months with disease modifying treatment)

What Isaac provides: Specialist care from diagnosis to treatment

All care provided virtually in patient’s home – except for imaging

Evidence for clinical effectiveness

Medication

3 months – 3 years

Time period over which ADAS-Cog 11 scores improve or remain steady with medications approved to treat Alzheimer disease (donepezil, galantamine, rivastigmine, and memantine) (meta-analysis of 224 studies)
US Preventive Services Task Force Recommendation Statement 2020 1

Cognitive therapy

92%

Proportion of participants in cognitive therapy that experienced improvement against their cognitive goals after three sessions.

Isaac Health data

Caregiver support

3 – 12 months

Time period over which psychoeducation interventions for caregivers resulted in a benefit for caregiver burden
US Preventive Services Task Force Recommendation Statement 2020 1

1: JAMA. 2020;323(8):764-785. doi:10.1001/jama.2019.22258

Benefits to MA plans and ACOs

Unique offering

to attract patients and caregivers and set your MA plan apart

Better outcomes

through early detection, delay of cognitive decline, risk reduction, advanced planning, care coordination (Stars relevant) and outstanding patient-centered care

Added value

through increased risk adjustment (see our White Paper), lower cost to diagnosis, lower cost of care due to delay of cognitive decline and care coordination, and Stars revenue

1: JAMA. 2020;323(8):764-785. doi:10.1001/jama.2019.22258
2: Adults in Healthcare – Outpatient 2019 (p. 36), see also AAN guideline published in Neurology. 2018;90:1-10. doi:10.1212/WNL.0000000000004826

Example Pilot design

Start date

Generally requires ~1 month preparation.

Time for review of outcomes

After 6 months

Key outcome metrics are:

  • Clinical: Observed vs. expected trajectory of clinical outcomes
  • Operational: Change in % with dementia diagnosis, PCP-to-Specialist time
  • Financial: Observed vs. expected cost of care trajectory (DiD)

Population

e.g., Whole at-risk population or a subset of counties

Reimbursement for diagnosis or treatment / management

Either: FFS CMS rates

OR: Episode-based rates for diagnosis (incl. imaging and labs where required) and therapy (per active month, covering medical and cognitive therapy) (full rate sheet can be provided)

Interested in connecting with us?

Book a time to connect with us to discuss how Isaac Health can support you

Key contacts

Joel Salinas, MD, MBA, MSc

(Chief Medical Officer)

Sean Zhao, FSA

(Senior Advisor )

Join our community

* indicates required